Literature DB >> 12048030

Antibiotic resistance and virulence properties of Pseudomonas aeruginosa strains from mechanically ventilated patients with pneumonia in intensive care units: comparison with imipenem-resistant extra-respiratory tract isolates from uninfected patients.

Patrick Di Martino1, Hélène Gagnière, Hugues Berry, Laurent Bret.   

Abstract

We investigated the epidemiology of antibiotic resistance and virulence properties among Pseudomonas aeruginosa clinical isolates collected in 1999 from patients hospitalized in the intensive care units of the centre hospitalier d'Orléans, in France. We compared the totality of the strains from mechanically ventilated patients with pneumonia (33 non-duplicate isolates, group 1) to 15 randomly chosen, imipenem-resistant, extra-respiratory tract isolates, collected from non-infected patients hospitalized in the same units (group 2). The isolates were serotyped, typed by random amplified polymorphic DNA (RAPD), and screened for their pneumocyte cell adherence, cytotoxicity, and antibiotic resistance. A total of 35 RAPD profiles were found, and only two profiles were encountered in both groups, demonstrating a high genetic diversity. 84.8% of the group 1 and 93.3% of the group 2 isolates adhered to A549 cells. Three non-exclusive adhesive patterns were observed: a diffuse adhesion in 38 isolates, a localized adhesion in 14 isolates, and an aggregative adhesion in seven isolates. 78.8% of the group 1 and 93.3% of the group 2 isolates were cytotoxic. Considering all 48 isolates, there was a strong and statistically significant correlation between cytotoxicity and adherence. Among the three dominant serotypes, O:12 isolates were in majority avirulent, but the great majority of O:1 and all the O:11 isolates were found adherent and cytotoxic. Gentamicin was the least active antibiotic for both groups, and ceftazidime was the most active antibiotic for group 1 and amikacin for group 2. The penicillinase production phenotype was significantly correlated with a decrease in P. aeruginosa virulence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048030     DOI: 10.1016/s1286-4579(02)01579-4

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  10 in total

1.  O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa.

Authors:  Karine Faure; David Shimabukuro; Temitayo Ajayi; Leonard R Allmond; Teiji Sawa; Jeanine P Wiener-Kronish
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  alpha5beta1 integrins and fibronectin are involved in adherence of the Pseudomonas aeruginosa ER97314 clinical strain to A549 cells.

Authors:  H Gagnière; P Di Martino
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

3.  Molecular Detection of the Virulent ExoU Genotype of Pseudomonas aeruginosa Isolated from Infected Surgical Incisions.

Authors:  Noha A Hassuna
Journal:  Surg Infect (Larchmt)       Date:  2016-07-21       Impact factor: 2.150

4.  Identification of biofilm-associated cluster (bac) in Pseudomonas aeruginosa involved in biofilm formation and virulence.

Authors:  Camille Macé; Damien Seyer; Chanez Chemani; Pascal Cosette; Patrick Di-Martino; Benoit Guery; Alain Filloux; Marc Fontaine; Virginie Molle; Guy-Alain Junter; Thierry Jouenne
Journal:  PLoS One       Date:  2008-12-09       Impact factor: 3.240

5.  Identification of multi-drug resistant Pseudomonas aeruginosa clinical isolates that are highly disruptive to the intestinal epithelial barrier.

Authors:  Olga Zaborina; Jonathan E Kohler; Yingmin Wang; Cindy Bethel; Olga Shevchenko; Licheng Wu; Jerrold R Turner; John C Alverdy
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-06-08       Impact factor: 3.944

6.  Correlations between Microbiological Outcomes and Clinical Responses in Patients with Severe Pneumonia.

Authors:  Sungmin Kiem; Jerome J Schentag
Journal:  Infect Chemother       Date:  2013-09-27

7.  Carbapenem-Resistant Pseudomonas aeruginosa Strains-Distribution of the Essential Enzymatic Virulence Factors Genes.

Authors:  Tomasz Bogiel; Małgorzata Prażyńska; Joanna Kwiecińska-Piróg; Agnieszka Mikucka; Eugenia Gospodarek-Komkowska
Journal:  Antibiotics (Basel)       Date:  2020-12-24

8.  Decoding Genetic Features and Antimicrobial Susceptibility of Pseudomonas aeruginosa Strains Isolated from Bloodstream Infections.

Authors:  Tomasz Bogiel; Dagmara Depka; Mateusz Rzepka; Agnieszka Mikucka
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

9.  Prevalence of virulence genes among bulgarian nosocomial and cystic fibrosis isolates of pseudomonas aeruginosa.

Authors:  Ivan Mitov; Tanya Strateva; Boyka Markova
Journal:  Braz J Microbiol       Date:  2010-09-01       Impact factor: 2.476

10.  Virulence Constitution of Multi-Drug-Resistant Pseudomonas aeruginosa in Upper Egypt.

Authors:  Noha A Hassuna; Sahar A Mandour; Ebtisam Samir Mohamed
Journal:  Infect Drug Resist       Date:  2020-02-19       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.